A Phase 1b/2 Study Of The Bet Inhibitor Zen003694 In Combination With Talazoparib For Treatment Of Patients With Tnbc Without Gbrca1/2 Mutations

CANCER RESEARCH(2021)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要